Targeting the MHC Ligandome by Use of TCR-Like Antibodies.

Høydahl, Lene Støkken; Frick, Rahel; Sandlie, Inger; Løset, Geir Åge

Høydahl, Lene Støkken; Frick, Rahel; Sandlie, Inger; Løset, Geir Åge.

Afiliación

Høydahl LS; Department of Immunology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway. l.s.hoydahl@medisin.uio.no.
Frick R; KG Jebsen Coeliac Disease Research Centre, University of Oslo, N-0372 Oslo, Norway. l.s.hoydahl@medisin.uio.no.
Sandlie I; Department of Immunology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway. rahel.frick@medisin.uio.no.
Løset GÅ; Department of Biosciences, University of Oslo, N-0316 Oslo, Norway. rahel.frick@medisin.uio.no.

Antibodies (Basel) ; 8(2)2019 May 09.

Article en En | MEDLINE | ID: mdl-31544838

Palabras clave

MHC; TCR-like antibodies; antigen-specific therapy; epitope

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antibodies (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google